Immunogenicity to biological drugs in psoriasis and psoriatic arthritis
Open Access
Abstract
Monoclonal antibodies or fusion proteins, defined as biological drugs, have modified the natural history of numerous immune-mediated disorders, allowing the development of therapies aimed at blocking the pathophysiological pathways of the disease, providing ...Keywords
This publication has 77 references indexed in Scilit:
- Methotrexate reduces immunogenicity in adalimumab treated rheumatoid arthritis patients in a dose dependent mannerAnnals of the Rheumatic Diseases, 2012
- Development of the IL‐12/23 antagonist ustekinumab in psoriasis: past, present, and future perspectivesAnnals of the New York Academy of Sciences, 2011
- Immunogenicity of rituximab in patients with severe pemphigusClinical Immunology, 2009
- Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)The Lancet, 2008
- Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trialJournal of the American Academy of Dermatology, 2008
- Infliximab maintains a high degree of clinical response in patients with active psoriatic arthritis through 1 year of treatment: results from the IMPACT 2 trialAnnals of the Rheumatic Diseases, 2007
- A proposed revision to the ACR20: The hybrid measure of American College of Rheumatology responseArthritis Care & Research, 2007
- A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasisJournal of the American Academy of Dermatology, 2007
- Infliximab induction therapy for patients with severe plaque-type psoriasis: A randomized, double-blind, placebo-controlled trialJournal of the American Academy of Dermatology, 2004
- Nuevas armas inmunológicas para la medicina del siglo XXI: Terapia biológica basada en el uso de anticuerpos monoclonales de última generaciónRevista médica de Chile, 2003